rs758115945
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):c.661G>A(p.Glu221Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,460,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000372.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250632Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135502
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460312Hom.: 0 Cov.: 33 AF XY: 0.0000303 AC XY: 22AN XY: 726348
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Oculocutaneous albinism type 1A Pathogenic:2
- -
- -
TYR-related disorder Pathogenic:1
The TYR c.661G>A variant is predicted to result in the amino acid substitution p.Glu221Lys. This variant has been reported in the compound heterozygous state in individuals with oculocutaneous albinism (King et al. 2003. PubMed ID: 13680365; Gao et al. 2017. PubMed ID: 28451379). This variant has also been detected in the compound heterozygous state in an individual undergoing testing for hypopigmentation at PreventionGenetics (internal data). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Given the evidence, we interpret this variant as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at